-
China, Saudi Arabia sign MoU on drug regulation
Li Li, commissioner of China's National Medical Products Administration (NMPA), signed a memorandum of understanding (MoU) on cooperation with Hisham S Aljadhey, chief executive officer of the Saudi Food and Drug Authority (SFDA), on Nov 1 in Beijing, to further enhance bilateral exchanges and cooperation in drug regulation.
-
NMPA signs letter of intent on cooperation with Danish Medicines Agency
Li Li, commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices in Beijing on Oct 24.
-
Li Li meets with head of Brazil’s Health Regulatory Agency
Li Li, commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Antonio Barra Torres, head of Brazil's Health Regulatory Agency (Anvisa), in Beijing on Oct 21.
